Immunitybio Announces $470 Million Equity And Debt Financing From Founder, Dr. Patrick Soon-Shiong And Nant Entities
Amount Raised
$470 Million
Round Type
Debt Financing
San DiegoBiotechnologyInvestors
Description
ImmunityBio, Inc. (NASDAQ: IBRX), a clinical-stage immunotherapy company, today announced that it has executed financing transactions resulting in approximately $200 million of proceeds to the Company through a financing including an exchange into equity of current debt and a new convertible debt instrument from Nant Capital, LLC, an entity affiliated with Dr. Patrick Soon-Shiong, the Company’s Founder, Executive Chairman and Global Chief Scientific and Medical Officer. With this new financing from Dr
Quick answer
ImmunityBio raised $470 Million in a Debt Financing round, dated September 11, 2023. Investors: Nant Capital, Dr. Soon Shiong and Nant Capital, LLC. ImmunityBio is based in San Diego, California, United States.
- How much did ImmunityBio raise?
- ImmunityBio raised $470 Million in a Debt Financing round on September 11, 2023.
- Who invested in ImmunityBio?
- Nant Capital, Dr. Soon Shiong and Nant Capital, LLC are named as investors in this round.
- What does ImmunityBio do?
- ImmunityBio, Inc. (formerly NantKwest, Inc.) is developing cell and immunotherapy products that are designed to help strengthen each patient’s natural immune system, potentially enabling it to outsmart the disease and..
- Where is ImmunityBio based and how big is it?
- ImmunityBio is based in San Diego, California, United States.
- Who are the decision-makers at ImmunityBio?
- Fundz holds 2 contacts at ImmunityBio, including the National Director, Key Accounts. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as ImmunityBio that raised within 45 days of this round, from Fundz verified event records.
- BrainBox raised $7.1M on October 26, 2023.
- 3Helix raised $3.7M (Seed) on October 26, 2023.
- Mustang Bio raised $4.7M (Seed) on October 26, 2023.
- Triveni Bio raised $92M (Series A) on October 26, 2023.
- Montinutra raised $2.2M (Seed) on October 26, 2023.
- Apothekary raised $3.2M (Seed) on October 26, 2023.
Who to call at ImmunityBio, and when
A new round usually means ImmunityBio is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day ImmunityBio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at ImmunityBio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at ImmunityBio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment ImmunityBio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
ImmunityBio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.